[title missed]

Corresponding author: Jia Zhiying, mldjzy@163.com

DOI: 10.12201/bmr.202605.00027

•  

  Abstract: [abstract missed]

  Key words:

  Submit time: 5 May 2026

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• 鲍呈洋, yangyingtao. Factors Influencing the Efficacy of Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer. 2025. doi: 10.12201/bmr.202511.00048

  韦蔚琦, Li Zhiqiong, Liang Zhiping. . 2026. doi: 10.12201/bmr.202601.00069

  Yao Genwu, Wang Yanwei, Guo Jinyi, Li Lulu, Dang Wenbo, Song Ailin. Advances in single-cell sequencing in the breast cancer. 2024. doi: 10.12201/bmr.202407.00053

  yuguozheng. Research Advances in Metadherin (MTDH) in Breast Cancer. 2026. doi: 10.12201/bmr.202601.00039

  ZHAO Qing, JING Jiangxin. Advances in the application of ultrasound-based radiomics in predicting molecular typing of breast cancer. 2024. doi: 10.12201/bmr.202410.00040

  Shi Shenghong. . 2024. doi: 10.12201/bmr.202411.00062

  杨鹤, zhaoqing, zhaihong. . 2024. doi: 10.12201/bmr.202411.00032

  Zhaoqing, Jing Jiangxin. Progress and status of ultrasound imaging in breast cancer. 2024. doi: 10.12201/bmr.202412.00053

  xiaqige, zhouwenxin, sunqinyu, yangchenxi, wangying. . 2025. doi: 10.12201/bmr.202512.00068

  Yuan Heqing, Shao Xiying. . 2025. doi: 10.12201/bmr.202504.00058

• ID	Submit time	Number	Download
  1	2026-03-20	10.12201/bmr.202605.00027V1	Download

• Public  Anonymous  To author only Submit Comments